FDA Issues Nationwide Notification of Recall of Certain Guidant Products
The Food and Drug Administration (FDA) notified health care providers and patients on June 17 that the Guidant Corporation was recalling certain of its implantable defibrillators and cardiac resynchronization therapy defibrillators because the devices could develop an internal short circuit without warning,
This premium content is locked for LawJournalNewsletters subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN LawJournalNewsletters
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already have an account? Sign In Now
For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.